299 related articles for article (PubMed ID: 29977225)
1. Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?
Rotondi M; Coperchini F; Latrofa F; Chiovato L
Front Endocrinol (Lausanne); 2018; 9():314. PubMed ID: 29977225
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D Reduces Thyroid Cancer Cells Migration Independently From the Modulation of CCL2 and CXCL8 Chemokines Secretion.
Coperchini F; Greco A; Croce L; Petrosino E; Grillini B; Magri F; Chiovato L; Rotondi M
Front Endocrinol (Lausanne); 2022; 13():876397. PubMed ID: 35498406
[TBL] [Abstract][Full Text] [Related]
3. Role of chemokine receptors in thyroid cancer and immunotherapy.
Coperchini F; Croce L; Marinò M; Chiovato L; Rotondi M
Endocr Relat Cancer; 2019 Aug; 26(8):R465-R478. PubMed ID: 31146261
[TBL] [Abstract][Full Text] [Related]
4. Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug.
Coperchini F; Greco A; Croce L; Pignatti P; Muzza M; Petrosino E; Teliti M; Magri F; Rotondi M
Biomed Pharmacother; 2024 Jan; 170():115974. PubMed ID: 38056240
[TBL] [Abstract][Full Text] [Related]
5. The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes.
Coperchini F; Croce L; Denegri M; Awwad O; Ngnitejeu ST; Magri F; Chiovato L; Rotondi M
Oncotarget; 2019 Nov; 10(60):6432-6443. PubMed ID: 31741708
[TBL] [Abstract][Full Text] [Related]
6. The multifaceted anti-cancer effects of BRAF-inhibitors.
Croce L; Coperchini F; Magri F; Chiovato L; Rotondi M
Oncotarget; 2019 Nov; 10(61):6623-6640. PubMed ID: 31762942
[TBL] [Abstract][Full Text] [Related]
7. CXCL8 in thyroid disease: from basic notions to potential applications in clinical practice.
Rotondi M; Coperchini F; Chiovato L
Cytokine Growth Factor Rev; 2013 Dec; 24(6):539-46. PubMed ID: 24011840
[TBL] [Abstract][Full Text] [Related]
8. Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers.
Do HTT; Lee CH; Cho J
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31991604
[TBL] [Abstract][Full Text] [Related]
9. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy.
Mishra P; Banerjee D; Ben-Baruch A
J Leukoc Biol; 2011 Jan; 89(1):31-9. PubMed ID: 20628066
[TBL] [Abstract][Full Text] [Related]
10. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
Soria G; Ben-Baruch A
Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
12. Chemokines in colon cancer progression.
Jia SN; Han YB; Yang R; Yang ZC
Semin Cancer Biol; 2022 Nov; 86(Pt 3):400-407. PubMed ID: 35183412
[TBL] [Abstract][Full Text] [Related]
13. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
[TBL] [Abstract][Full Text] [Related]
14. Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion.
Coperchini F; Pignatti P; Leporati P; Carbone A; Croce L; Magri F; Chiovato L; Rotondi M
Endocrine; 2016 Oct; 54(1):123-128. PubMed ID: 26450713
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells.
Fallahi P; Foddis R; Elia G; Ragusa F; Patrizio A; Frenzilli G; Benvenga S; Cristaudo A; Antonelli A; Ferrari SM
Mol Med Rep; 2018 May; 17(5):7415-7420. PubMed ID: 29568907
[TBL] [Abstract][Full Text] [Related]
16. PFOA, PFHxA and C6O4 differently modulate the expression of CXCL8 in normal thyroid cells and in thyroid cancer cell lines.
Coperchini F; De Marco G; Croce L; Denegri M; Greco A; Magri F; Tonacchera M; Imbriani M; Rotondi M; Chiovato L
Environ Sci Pollut Res Int; 2023 May; 30(23):63522-63534. PubMed ID: 37052835
[TBL] [Abstract][Full Text] [Related]
17. The role of chemokines in melanoma tumor growth and metastasis.
Payne AS; Cornelius LA
J Invest Dermatol; 2002 Jun; 118(6):915-22. PubMed ID: 12060384
[TBL] [Abstract][Full Text] [Related]
18. Iodide-induced chemokines and genes related to immunological function in cultured human thyroid follicles in the presence of thyrotropin.
Yamazaki K; Tanigawa K; Suzuki K; Yamada E; Yamada T; Takano K; Obara T; Sato K
Thyroid; 2010 Jan; 20(1):67-76. PubMed ID: 20025541
[TBL] [Abstract][Full Text] [Related]
19. Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer.
Motyka J; Gacuta E; Kicman A; Kulesza M; Ławicki P; Ławicki S
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431173
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression and localization of cytokines/chemokines/growth factors in gastric cancer.
Raja UM; Gopal G; Shirley S; Ramakrishnan AS; Rajkumar T
Cytokine; 2017 Jan; 89():82-90. PubMed ID: 27793525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
